Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization

• Nevien Ismail,
• Subir Karmakar,
• Parna Bhattacharya,
• Telly Sepahpour,
• Kazuyo Takeda,
• Shinjiro Hamano,
• Greg Matlashewski,
• Abhay R. Satoskar,
• Sreenivas Gannavaram,
• Ranadhir Dey,
• Hira L. Nakhasi

Affiliations

Nevien Ismail

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Subir Karmakar

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Parna Bhattacharya

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Telly Sepahpour

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Kazuyo Takeda

Laboratory of Clinical Hematology, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Shinjiro Hamano

Department of Parasitology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan

Greg Matlashewski

Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada

Abhay R. Satoskar

Department of Pathology and Microbiology, Ohio State University, Columbus, OH, United States

Sreenivas Gannavaram

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Ranadhir Dey

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Hira L. Nakhasi

Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States